AstraZeneca to Acquire Neogene Therapeutics, for up to $320M
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Vida Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
New York, NY (PRWEB) October 27, 2022 -- The Conference Forum announced the launch of the 9th annual Immuno-Oncology 360º Summit (IO360°) taking place
Capstan Therapeutics has launched to combine cell therapy and genetic medicines to bring safer medicines to patients in multiple indications.
Capstan Therapeutics, a University of Pennsylvania spinout, is now out of stealth with technology that could enable new medicines that work by engineering cells inside of a patient. Penn biotech pioneers Carl June and Drew Weissman are among the scientific co-founders of this startup, which has aims to develop therapies for fibrosis, cancer, inflammation, and genetic diseases.
Investegate announcements from Prothena Corporation plc, Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors